Diffusion-Weighted MRI in the Evaluation of Early-Stage Breast Cancer Treated with a Short Preoperative Radiotherapy: Preliminary Results.

Ki-67 index apparent diffusion coefficient diffusion-weighted MRI early-stage breast cancer neoadjuvant radiotherapy

Journal

Journal of the Belgian Society of Radiology
ISSN: 2514-8281
Titre abrégé: J Belg Soc Radiol
Pays: England
ID NLM: 101698198

Informations de publication

Date de publication:
2023
Historique:
received: 22 03 2022
accepted: 30 12 2022
entrez: 23 2 2023
pubmed: 24 2 2023
medline: 24 2 2023
Statut: epublish

Résumé

To assess tumor response with diffusion-weighted MRI (DW-MRI) after a short preoperative radiotherapy in early-stage breast cancer (BCa). This was a prospective, single-center pilot study. 3T-MRI were performed before and after radiotherapy. The longest diameter (LD) and the apparent diffusion coefficient (ADC) value of a region of interest (ROI) of the tumors were recorded. Histopathology and immunohistochemistry, including the Ki-67 index of the core biopsy and of the surgical specimen, were the reference standards. Nineteen patients with 22 early-stage BCa were included. The mean ROI ADC value was 1.093 ± 0.278 × 10 In early-stage BCa, a significant increase in ROI-ADC at DWI and a significant decrease in Ki-67 index were observed after a short preoperative radiotherapy, suggesting early tumor response.

Identifiants

pubmed: 36817566
doi: 10.5334/jbsr.2815
pmc: PMC9912849
doi:

Types de publication

Journal Article

Langues

eng

Pagination

8

Informations de copyright

Copyright: © 2023 The Author(s).

Déclaration de conflit d'intérêts

The authors have no competing interests to declare.

Références

Radiology. 2010 Oct;257(1):56-63
pubmed: 20851939
Radiology. 2018 Dec;289(3):618-627
pubmed: 30179110
Breast Cancer Res Treat. 2014 Aug;147(1):95-102
pubmed: 25106660
Radiology. 2012 Jun;263(3):663-72
pubmed: 22623692
J Natl Cancer Inst. 2011 Nov 16;103(22):1656-64
pubmed: 21960707
Biometrics. 1947 Sep;3(3):119-22
pubmed: 18903631
J Natl Cancer Inst. 2013 Mar 6;105(5):321-33
pubmed: 23297042
Radiother Oncol. 2022 May;170:118-121
pubmed: 35257850
J Am Coll Radiol. 2009 Dec;6(12):851-60
pubmed: 19945040
J Magn Reson Imaging. 2017 Feb;45(2):337-355
pubmed: 27690173
Breast Cancer Res Treat. 2012 Aug;135(1):17-28
pubmed: 22476850
Oncotarget. 2017 Dec 11;9(6):7088-7100
pubmed: 29467952
Ann Oncol. 2015 Sep;26 Suppl 5:v8-30
pubmed: 26314782
Radiology. 2017 Nov;285(2):358-375
pubmed: 29045232
Ann Oncol. 2015 Aug;26(8):1533-46
pubmed: 25939896
J Natl Cancer Inst Monogr. 2015 May;2015(51):21-3
pubmed: 26063880
J Clin Oncol. 2007 Aug 1;25(22):3259-65
pubmed: 17577015
Eur Radiol. 2022 Jun;32(6):4067-4078
pubmed: 35015127
Ann Oncol. 2015 Feb;26(2):307-13
pubmed: 25411418
J Magn Reson Imaging. 2019 Dec;50(6):1742-1753
pubmed: 31026118
Med Oncol. 2012 Jun;29(2):425-31
pubmed: 21286861
Breast J. 2011 Nov-Dec;17(6):610-9
pubmed: 21929557
J Am Coll Radiol. 2017 Nov;14(11S):S462-S475
pubmed: 29101985
Acad Radiol. 2019 Oct;26(10):1352-1357
pubmed: 30711409
Psychometrika. 1947 Jun;12(2):153-7
pubmed: 20254758

Auteurs

Nathalie Hottat (N)

University Hospital Brugmann, BE.

Jacques Jani (J)

University Hospital Brugmann, BE.

Dominique Badr (D)

University Hospital Brugmann, BE.

André Nazac (A)

University Hospital Brugmann, BE.

Sophie Lecomte (S)

University Hospital Brugmann, BE.

Mieke Cannie (M)

University Hospital Brugmann, BE.

Classifications MeSH